FDA Clears Roche Elecsys pTau217 Blood Test for Alzheimer’s Detection
The Food and Drug Administration (FDA) has cleared the Roche Elecsys Phospho-Tau (217P) Plasma (pTau217) blood test. The…
Roche seeks Japan approval for Elecsys pTau217 Alzheimer’s blood test
KEY POINTSRoche Diagnostics files in Japan for Elecsys pTau217 blood test for Alzheimer’s-related biomarker measurement in plasmaElecsys pTau217…
Test that could identify signs of Alzheimer’s disease 20 years earlier greenlit for trials
The ability to test for signs of Alzheimer’s disease decades earlier could be a step closer with a…
Roche to Present New Elecsys Alzheimer’s Blood Test Data at AAIC 2026
Roche announced it will present 18 oral and poster presentations from its Alzheimer’s disease portfolio at the Alzheimer’s…
Roche secures CE mark for Alzheimer’s blood test
Roche Holding AG secured CE marking for the Elecsys plasma phosphorylated-tau 217 blood test designed to rule in…